(Q39697091)

14 September 2017

Efficient delivery of liposome-mediated MGMT-siRNA reinforces the cytotoxity of temozolomide in GBM-initiating cells (English)

1 reference

14 September 2017

0 references

T Kato

1

1 reference

14 September 2017

A Natsume

2

1 reference

14 September 2017

H Toda

3

1 reference

14 September 2017

H Iwamizu

4

1 reference

14 September 2017

T Sugita

5

1 reference

14 September 2017

R Hachisu

6

1 reference

14 September 2017

R Watanabe

7

1 reference

14 September 2017

K Yuki

8

1 reference

14 September 2017

K Motomura

9

1 reference

14 September 2017

K Bankiewicz

10

1 reference

14 September 2017

T Wakabayashi

11

1 reference

14 September 2017

language of work or name

1 reference

3 June 2010

1 reference

14 September 2017

1 reference

14 September 2017

17

1 reference

14 September 2017

11

1 reference

14 September 2017

1363-1371

1 reference

https://scigraph.springernature.com/pub.10.1038/gt.2010.88

14 September 2017

0 references

cites work

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.88

MGMT: its role in cancer aetiology and cancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.88

Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.88

Identification of human brain tumour initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.88

Glioma stem cells promote radioresistance by preferential activation of the DNA damage response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.88

Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.88

Induction of oligodendrogenesis in glioblastoma-initiating cells by IFN-mediated activation of STAT3 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.88

A side order of stem cells: the SP phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.88

A distinct "side population" of cells with high drug efflux capacity in human tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.88

Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2- cancer cells are similarly tumorigenic

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.88

Knocking down barriers: advances in siRNA delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.88

Tumour stem cells and drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.88

Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.88

In vitro drug response and molecular markers associated with drug resistance in malignant gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.88

Biochemical changes associated with a multidrug-resistant phenotype of a human glioma cell line with temozolomide-acquired resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.88

O6-methylguanine DNA methyltransferase and p53 status predict temozolomide sensitivity in human malignant glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.88

Ubiquitination-dependent proteolysis of O6-methylguanine-DNA methyltransferase in human and murine tumor cells following inactivation with O6-benzylguanine or 1,3-bis(2-chloroethyl)-1-nitrosourea

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.88

Targeted modulation of MGMT: clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.88

Inhibition of DNA repair for sensitizing resistant glioma cells to temozolomide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.88

Phase II trial of carmustine plus O(6)-benzylguanine for patients with nitrosourea-resistant recurrent or progressive malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.88

Phase I trial of temozolomide plus O6-benzylguanine for patients with recurrent or progressive malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.88

Cationic liposome-mediated RNA transfection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.88

Cationic liposome-mediated transfection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.88

Resolution of liver cirrhosis using vitamin A-coupled liposomes to deliver siRNA against a collagen-specific chaperone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.88

Convection-enhanced delivery of AAV vector in parkinsonian monkeys; in vivo detection of gene expression and restoration of dopaminergic function using pro-drug approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.88

Convection-enhanced delivery of adeno-associated virus type 2 (AAV2) into the striatum and transport of AAV2 within monkey brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.88

Safety of real-time convection-enhanced delivery of liposomes to primate brain: a long-term retrospective

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.88

Defective repair of alkylated DNA by human tumour and SV40-transformed human cell strains

21 January 2018

2 references

https://api.crossref.org/works/10.1038%2FGT.2010.88

21 January 2018

https://api.crossref.org/works/10.1038%2FGT.2010.88

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/GT.2010.88

1 reference

14 September 2017

1 reference